Literature DB >> 10540335

The extrafollicular-to-follicular transition of human B lymphocytes: induction of functional globotriaosylceramide (CD77) on high threshold occupancy of CD40.

N McCloskey1, J D Pound, M J Holder, J M Williams, L M Roberts, J M Lord, J Gordon.   

Abstract

Amongst lymphocytes, expression of CD77 (globotriaosylceramide, Gb3) is exclusive to B cells of the germinal center (GC). Its acquisition by extrafollicular B cells may thus herald their commitment to a follicular response. Here we show that high threshold occupancy of CD40 by its cognate ligand (CD40L) promotes rapid induction of CD77 expression in non-GC (CD38(lo)) B cells. The kinetics of CD77 acquisition mirrored those of GC-related markers CD95 and CD86 but contrasted with the more delayed increase in CD38 expression. Induction of CD77 was not a simple consequence of cell cycle entry: other conditions of stimulation equally capable of driving proliferation failed to promote CD77 expression. CD77 was functional in that cells were now sensitive to Verotoxin-1, an Escherichia coli-derived ligand of Gb3. These data indicate that acquisition by extrafollicular B cells of CD77 results from high threshold occupancy of CD40, a situation that should be reached physiologically only once a critical level of T cell priming has been achieved.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10540335     DOI: 10.1002/(SICI)1521-4141(199910)29:10<3236::AID-IMMU3236>3.0.CO;2-T

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  13 in total

Review 1.  Fortifying B cells with CD154: an engaging tale of many hues.

Authors:  J Gordon; J D Pound
Journal:  Immunology       Date:  2000-07       Impact factor: 7.397

Review 2.  Follicular dendritic cell networks of primary follicles and germinal centers: phenotype and function.

Authors:  Christopher D C Allen; Jason G Cyster
Journal:  Semin Immunol       Date:  2008-02-07       Impact factor: 11.130

3.  Naive CD4 T cells constitutively express CD40L and augment autoreactive B cell survival.

Authors:  Robin Lesley; Lisa M Kelly; Ying Xu; Jason G Cyster
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-30       Impact factor: 11.205

4.  Lack of Shiga-like toxin binding sites in germinal centres of mouse lymphoid tissues.

Authors:  Yasuyuki Imai; Takashi Fukui; Asano Ikegaya; Tomoyuki Ishikawa; Yousuke Ono; Kohta Kurohane
Journal:  Immunology       Date:  2002-04       Impact factor: 7.397

5.  CD5-positive and CD5-negative human B cells converge to an indistinguishable population on signalling through B-cell receptors and CD40.

Authors:  A Gagro; N McCloskey; A Challa; M Holder; G Grafton; J D Pound; J Gordon
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

6.  Production of secretory immunoglobulin A against Shiga toxin-binding subunits in mice by mucosal immunization.

Authors:  Yasuyuki Imai; Rio Nagai; Yousuke Ono; Tomoyuki Ishikawa; Hiroki Nakagami; Takashi Tanikawa; Kohta Kurohane
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

7.  Comprehensive FISH probe design tool applied to imaging human immunoglobulin class switch recombination.

Authors:  Jakub Nedbal; Philip S Hobson; David J Fear; Rainer Heintzmann; Hannah J Gould
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

8.  Analysis of intergenic transcription and histone modification across the human immunoglobulin heavy-chain locus.

Authors:  Muslima Chowdhury; Omid Forouhi; Sandeep Dayal; Natalie McCloskey; Hannah J Gould; Gary Felsenfeld; David J Fear
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-03       Impact factor: 11.205

9.  Dopamine targets cycling B cells independent of receptors/transporter for oxidative attack: Implications for non-Hodgkin's lymphoma.

Authors:  Elizabeth J Meredith; Michelle J Holder; Anders Rosén; Adrian Drake Lee; Martin J S Dyer; Nicholas M Barnes; John Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-28       Impact factor: 11.205

Review 10.  Therapeutic Uses of Bacterial Subunit Toxins.

Authors:  Clifford Lingwood
Journal:  Toxins (Basel)       Date:  2021-05-26       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.